Einzelheiten zum Produkt
Place of Origin: China
Markenname: BBCA Pharma
Model Number: 26787-78-0
Zahlungs- und Versandbedingungen
Herkunftsland: |
Vom Lieferanten angegeben |
Hersteller: |
Vom Lieferanten angegeben |
Bilden: |
Pulver |
Grad: |
Medizinqualität |
Darreichungsform: |
Trockensuspension |
Verabreichungsweg: |
Oral |
Produktname: |
Pulver zum Einnehmen |
Typ: |
OTC |
Herkunftsland: |
Vom Lieferanten angegeben |
Hersteller: |
Vom Lieferanten angegeben |
Bilden: |
Pulver |
Grad: |
Medizinqualität |
Darreichungsform: |
Trockensuspension |
Verabreichungsweg: |
Oral |
Produktname: |
Pulver zum Einnehmen |
Typ: |
OTC |
Powder For Oral is an over-the-counter (OTC) medication designed in a dry suspension form, providing an effective and convenient way to administer Clavulanate Potassium. This product is specially formulated to ensure stability and ease of use, making it suitable for a wide range of patients who require an oral antibiotic treatment. The dry suspension form allows the powder to be reconstituted with water before use, ensuring accurate dosing and enhanced shelf life compared to pre-mixed liquid formulations.
One of the key active ingredients in this product is Clavulanate Potassium, a beta-lactamase inhibitor that works synergistically with certain antibiotics to combat bacterial infections. Clavulanate Potassium helps to overcome bacterial resistance by inhibiting enzymes that would otherwise degrade the antibiotic, thereby enhancing the effectiveness of the treatment. This makes Powder For Oral a valuable option for treating infections caused by beta-lactamase-producing bacteria, which are often resistant to other antibiotics alone.
The dry suspension format of Powder For Oral provides several advantages. Firstly, it ensures a longer shelf life of up to 3 years when stored properly, which is particularly beneficial for pharmacies, healthcare providers, and patients who may not use the medication immediately. Secondly, the powder form reduces the risk of degradation that can occur in liquid suspensions, maintaining the potency and efficacy of Clavulanate Potassium throughout the product's lifespan. When reconstituted, the suspension offers a palatable and easy-to-swallow solution, improving patient compliance, especially among children and elderly patients.
Safety is paramount with any medication, and Powder For Oral includes clear safety information to ensure proper use. It is essential to keep the product out of reach of children to prevent accidental ingestion or misuse. Proper storage conditions should be followed to maintain the integrity and effectiveness of the product. Users should also carefully follow the reconstitution instructions and dosage recommendations provided by healthcare professionals or indicated on the packaging.
The versatility of Powder For Oral makes it suitable for treating a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and other conditions where Clavulanate Potassium is indicated. The OTC status of this product allows patients to obtain it without a prescription, providing easier access to essential antibiotic therapy when needed. However, it is always recommended to consult a healthcare professional before starting any new medication to ensure proper diagnosis and treatment.
In summary, Powder For Oral is a reliable and effective OTC medication in dry suspension form containing Clavulanate Potassium. Its formulation ensures a long shelf life of three years, making it a practical choice for both healthcare providers and patients. The inclusion of Clavulanate Potassium enhances the antibiotic's ability to fight resistant bacterial strains, improving treatment outcomes. With clear safety instructions to keep the product out of reach of children and proper usage guidance, Powder For Oral offers a safe and user-friendly option for managing bacterial infections. Whether for pediatric or adult use, this dry suspension product provides the benefits of Clavulanate Potassium in a stable, easy-to-administer form, helping to promote effective and convenient antibiotic therapy.
The BBCA Pharma Powder For Oral product, model number 26787-78-0, is specifically designed for oral consumption and is ideal for various application occasions and scenarios. Originating from China and manufactured by a supplier specified by the manufacturer, this high-quality powder is intended to be used as an oral suspension. The product requires mixing with water before consumption, ensuring ease of administration and accurate dosing, making it suitable for both clinical and home settings.
This powder is particularly effective in scenarios where oral administration is preferred or necessary, such as in pediatric care, where swallowing tablets can be challenging. The powder, when prepared as a suspension, facilitates easier ingestion and better patient compliance. It is commonly used in the treatment of bacterial infections requiring the combined effects of Amoxicillin and Clavulanate Potassium for Suspension, making it an essential medication in both hospital and outpatient environments.
In addition, BBCA Pharma’s powder is widely applied in situations demanding rapid and effective antibiotic therapy. The suspension form allows healthcare providers to adjust doses precisely based on the patient's age, weight, and severity of infection. This flexibility makes it ideal for use in clinics, hospitals, and even in remote areas where liquid formulations might be unavailable.
Another common scenario for using this powder is in community health programs aimed at managing respiratory tract infections, urinary tract infections, and skin infections. The portability of the powder form and its easy preparation as a suspension make it convenient for distribution and use in field conditions. It supports effective treatment adherence due to its pleasant taste and ease of swallowing once mixed with water.
Overall, the BBCA Pharma Powder For Oral, model number 26787-78-0, offers a versatile and practical solution for oral antibiotic therapy. Its intended use as an oral suspension containing Amoxicillin and Clavulanate Potassium for Suspension ensures it meets the needs of various patient populations and treatment settings, enhancing therapeutic outcomes through reliable and convenient administration.
BBCA Pharma offers customized product solutions for the Powder For Oral, model number 26787-78-0, originating from China. Our manufacturing process is specified by the supplier to ensure the highest quality standards. The active ingredient in this OTC product is Paracetamol, formulated to meet diverse customer needs.
We provide tailored customization services to accommodate various requirements, including formulations that may involve Amoxicillin, Amoxicillin and Clavulanate Potassium for Suspension, and Clavulanate Potassium. Our expertise allows us to modify the powder composition to suit specific therapeutic applications while maintaining safety and efficacy.
Safety information is a priority; therefore, all customized powders come with clear instructions to keep out of reach of children. Trust BBCA Pharma for reliable and compliant customization of Powder For Oral products designed to meet market demands and regulatory standards.
For technical support and services related to the Powder For Oral product, please refer to the product manual included in the packaging for detailed usage instructions and safety information. Ensure the product is stored in a cool, dry place away from direct sunlight to maintain its efficacy.
If you experience any issues or have questions regarding the product, consult your healthcare provider or pharmacist for professional advice. They can provide guidance on proper dosage, administration, and potential interactions with other medications.
For further assistance, please visit our official website where you can find FAQs, troubleshooting tips, and additional resources to help you get the most out of the Powder For Oral product.
Always ensure that the product is used in accordance with prescribed guidelines and never exceed the recommended dosage. Keep out of reach of children and report any adverse reactions to your healthcare professional immediately.